MDMA-like Stimulus Effects of Hallucinogens in Male Fawn-Hooded Rats
Overview
Pharmacology
Psychology
Social Sciences
Authors
Affiliations
A two-lever, food-motivated, operant technique was employed to train the purportedly serotonergically dysfunctional Fawn-Hooded (FH) rat to discriminate 1.5 mg/kg MDMA. Once all 10 male subjects learned the MDMA-vehicle discrimination at criterion performance level, doses different than the training dose were used to generate a dose-response discrimination gradient. The ED50 value of MDMA was shown to be 0.136 mg/kg, not significantly different from that of previously trained Sprague-Dawley male rats. Thus, the Fawn-Hooded rat appears to not differ in its sensitivity to lower doses of MDMA. Testing for MDMA-like stimulus generalizations with other drugs indicated that the MDMA derivative MDE produced generalization at a dose of 2.25 mg/kg and allowed for an ED50 value of 0.496 mg/kg. Like MDE, the testing of alpha-ethyltryptamine was shown to produce MDMA-like responding. Lastly, a dose of 0.12 mg/kg LSD produced 90% MDMA-lever selection. In contrast to MDMA generalizations to these three drugs, testing of cocaine at doses of 2.5-10 mg/kg and mescaline at 8-14 mg/kg did not produce MDMA-like discriminative effects. The results of this testing in the presumably serotonergically dysfunctional Fawn-Hooded rat would indicate that this line not only can discriminate MDMA as well as heterogenous-bred lines, but also shows the same discriminative generalizations and nongeneralizations from MDMA to serotonergic and dopaminergic agents.
Abate C, Young R, Dukat M, Glennon R Psychopharmacology (Berl). 2024; .
PMID: 39731580 DOI: 10.1007/s00213-024-06738-y.
α-Ethyltryptamine: A Ratiocinatory Review of a Forgotten Antidepressant.
Glennon R, Dukat M ACS Pharmacol Transl Sci. 2023; 6(12):1780-1789.
PMID: 38093842 PMC: 10714429. DOI: 10.1021/acsptsci.3c00139.
Locomotor, discriminative stimulus, and place conditioning effects of MDAI in rodents.
Gatch M, Dolan S, Forster M Behav Pharmacol. 2016; 27(6):497-505.
PMID: 27028902 PMC: 4965292. DOI: 10.1097/FBP.0000000000000237.
Eshleman A, Forster M, Wolfrum K, Johnson R, Janowsky A, Gatch M Psychopharmacology (Berl). 2013; 231(5):875-88.
PMID: 24142203 PMC: 3945162. DOI: 10.1007/s00213-013-3303-6.
Gatch M, Rutledge M, Carbonaro T, Forster M Psychopharmacology (Berl). 2009; 204(4):715-24.
PMID: 19288085 PMC: 2865430. DOI: 10.1007/s00213-009-1501-z.